Cidara Therapeutics Inc. (CDTX) Gained 5.33% or 0.2 To Price $3.95 On Tuesday

Cidara Therapeutics Inc. (CDTX) gained 5.33% or 0.2 to $3.95. It is about 122866 shares traded, which is 28.84% compare to the average total volume 426064. The market cap of CDTX is $82.05 million. The year to date change is -46.04%. The 52 week price range is from $3.7 to $8.8. Price of CDTX have changed -3.85% during last week. It have changed -52.53% over last month, -48.28% over last 3 months, -45.65% over last 6 months and -42.75% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CDTX is 6.00. It is 51.90% above current price. The 200-day Moving Averages for CDTX is 7.00. It is 77.22% above current price. The 52-week High is 8.8. It is 122.78% from the current price. The 52-week Low is 3.7. It is -6.33% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CDTX is 2.12 on 2018-03-29. Short % to float is 4.63%. There are some statistics of CDTX. It is has market cap $82.05 million. The share outstanding is 20.77 million. The average volume is 426064. It has 232.25M cash and 19.68M in debt. The percent of top 15 Institution holding is 83.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CDTX is -75.35%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CDTX is -59.92%.


Share this post